Search Results - "Poole, James C."
-
1
Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats
Published in Journal of applied physiology (1985) (01-06-2012)“…There is currently no direct, facile method to determine total-body skeletal muscle mass for the diagnosis and treatment of skeletal muscle wasting conditions…”
Get full text
Journal Article -
2
Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution method
Published in Journal of cachexia, sarcopenia and muscle (01-09-2013)“…Background We recently validated in cross-sectional studies a new method to determine total body creatine pool size and skeletal muscle mass based on D 3…”
Get full text
Journal Article -
3
Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D 3 -creatine dilution method
Published in Journal of cachexia, sarcopenia and muscle (01-09-2013)“…We recently validated in cross-sectional studies a new method to determine total body creatine pool size and skeletal muscle mass based on D -creatine dilution…”
Get full text
Journal Article -
4
Longitudinal determination of total body creatine pool size and skeletal muscle mass in rats by D 3 ‐creatine dilution
Published in The FASEB journal (01-04-2013)“…Abstract only We recently described a new method to determine total body creatine pool size and skeletal muscle mass based on dilution of an oral dose of D 3…”
Get full text
Journal Article -
5
-
6
Disposition kinetics of ML-1035 sulfoxide enantiomers and the prochiral sulfide in rats
Published in Chirality (New York, N.Y.) (1993)“…ML-1035, 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethyl-amino)ethyl]benzamide, is a sulfoxide compound and a racemic gastroprokinetic agent with…”
Get more information
Journal Article -
7
Validation of a column-switching high-performance liquid chromatographic (HPLC) method for determination of ML-1035 and its five metabolites in plasma
Published in Pharmaceutical research (01-01-1992)“…A fully automated column-switching HPLC procedure has been developed and validated for quantitation of ML-1035 and its five metabolites in plasma employing…”
Get full text
Journal Article -
8
Determination of bioavailability and systemically available fractions of drugs undergoing reversible metabolism: application to 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethylamino)ethyl]benzamide and its sulfide and sulfone metabolites in rats
Published in Journal of pharmaceutical sciences (01-03-1994)“…Methods are discussed which permit the calculation of the bioavailability (F) and fraction of an oral dose entering the central circulation (f) of a drug and…”
Get more information
Journal Article -
9
Pharmacokinetics and metabolic interconversion of intravenous 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl] benzamide and its sulfide and sulfone metabolites in rats
Published in Journal of pharmaceutical sciences (01-07-1993)“…The pharmacokinetics of a new 5-hydroxytryptamine (5HT3) receptor antagonist, 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl] benzamide…”
Get more information
Journal Article -
10
Column-switching liquid chromatographic determination of ML-1035 sulphoxide and its sulphone and sulphide metabolites in rat urine
Published in Journal of pharmaceutical and biomedical analysis (1991)“…A fully automated column-switching LC assay has been developed for the simultaneous determination of a gastroprokinetic agent, ML-1035 sulphoxide, and its…”
Get more information
Journal Article